BIOGEN INC. Tax Withholding Paid on Stock Awards
BIOGEN INC. (BIIB) reported Tax Withholding Paid on Stock Awards of $55.10 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-04-29
- BIOGEN INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $55.10M, a 126.75% increase year-over-year.
- BIOGEN INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was -$3.00M.
- BIOGEN INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was -$5.20M.
- BIOGEN INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-06-30 was -$6.10M.
- BIOGEN INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $10.00M, a 68.05% decline from fiscal 2024.
- BIOGEN INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $31.30M, a 29.35% decline from fiscal 2023.
- BIOGEN INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $44.30M, a 2231.58% increase from fiscal 2022.
- BIOGEN INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $1.90M, a 171.43% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-03-31 | $55.10M 10-Q · filed 2026-04-29 | $52.10M derived: sum of 2 quarters · filed 2026-04-29 | $46.90M derived: sum of 3 quarters · filed 2026-04-29 | $40.80M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$8.20M derived: sum of 2 quarters · filed 2026-02-06 | -$14.30M derived: sum of 3 quarters · filed 2026-02-06 | $10.00M 10-K · filed 2026-02-06 |
| 2025-09-30 | -$5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$11.30M derived: sum of 2 quarters · filed 2025-10-30 | $13.00M 10-Q · filed 2025-10-30 | $9.50M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | -$6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $18.20M 10-Q · filed 2025-07-31 | $14.70M derived: sum of 3 quarters · filed 2026-04-29 | $8.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $24.30M 10-Q · filed 2026-04-29 | $20.80M derived: sum of 2 quarters · filed 2026-04-29 | $14.80M derived: sum of 3 quarters · filed 2026-04-29 | $8.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$9.50M derived: sum of 2 quarters · filed 2026-02-06 | -$15.60M derived: sum of 3 quarters · filed 2026-02-06 | $31.30M 10-K · filed 2026-02-06 |
| 2024-09-30 | -$6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$12.10M derived: sum of 2 quarters · filed 2025-10-30 | $34.80M 10-Q · filed 2025-10-30 | $31.10M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-06-30 | -$6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $40.80M 10-Q · filed 2025-07-31 | $37.10M derived: sum of 3 quarters · filed 2026-02-06 | $30.50M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-03-31 | $46.90M 10-Q · filed 2025-05-01 | $43.20M derived: sum of 2 quarters · filed 2026-02-06 | $36.60M derived: sum of 3 quarters · filed 2026-02-06 | $31.10M derived: sum of 4 quarters · filed 2026-02-06 |
| 2023-12-31 | -$3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$10.30M derived: sum of 2 quarters · filed 2026-02-06 | -$15.80M derived: sum of 3 quarters · filed 2026-02-06 | $44.30M 10-K · filed 2026-02-06 |
| 2023-09-30 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$12.10M derived: sum of 2 quarters · filed 2024-10-30 | $48.00M 10-Q · filed 2024-10-30 | $44.10M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -$5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $54.60M 10-Q · filed 2024-08-01 | $50.70M derived: sum of 3 quarters · filed 2025-02-12 | $45.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $60.10M 10-Q · filed 2024-04-24 | $56.20M derived: sum of 2 quarters · filed 2025-02-12 | $50.50M derived: sum of 3 quarters · filed 2025-02-12 | $41.20M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$9.60M derived: sum of 2 quarters · filed 2025-02-12 | -$18.90M derived: sum of 3 quarters · filed 2025-02-12 | $1.90M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$15.00M derived: sum of 2 quarters · filed 2023-11-08 | $5.80M 10-Q · filed 2023-11-08 | -$1.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $11.50M 10-Q · filed 2023-07-25 | $3.90M derived: sum of 3 quarters · filed 2024-02-14 | -$2.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $20.80M 10-Q · filed 2023-04-25 | $13.20M derived: sum of 2 quarters · filed 2024-02-14 | $7.30M derived: sum of 3 quarters · filed 2024-02-14 | -$5.60M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$13.50M derived: sum of 2 quarters · filed 2024-02-14 | -$26.40M derived: sum of 3 quarters · filed 2024-02-14 | $700.00K 10-K · filed 2024-02-14 |
| 2021-09-30 | -$5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$18.80M derived: sum of 2 quarters · filed 2022-10-25 | $8.30M 10-Q · filed 2022-10-25 | $1.10M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-06-30 | -$12.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $14.20M 10-Q · filed 2022-07-20 | $7.00M derived: sum of 3 quarters · filed 2023-02-15 | -$400.00K derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-03-31 | $27.10M 10-Q · filed 2022-05-03 | $19.90M derived: sum of 2 quarters · filed 2023-02-15 | $12.50M derived: sum of 3 quarters · filed 2023-02-15 | $2.10M derived: sum of 4 quarters · filed 2023-02-15 |
| 2020-12-31 | -$7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$14.60M derived: sum of 2 quarters · filed 2023-02-15 | -$25.00M derived: sum of 3 quarters · filed 2023-02-15 | $4.60M 10-K · filed 2023-02-15 |
| 2020-09-30 | -$7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$17.80M derived: sum of 2 quarters · filed 2021-10-20 | $11.80M 10-Q · filed 2021-10-20 | -$5.10M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | -$10.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $19.20M 10-Q · filed 2021-07-22 | $2.30M derived: sum of 3 quarters · filed 2022-02-03 | -$4.40M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | $29.60M 10-Q · filed 2021-04-22 | $12.70M derived: sum of 2 quarters · filed 2022-02-03 | $6.00M derived: sum of 3 quarters · filed 2022-02-03 | -$2.60M derived: sum of 4 quarters · filed 2022-02-03 |
| 2019-12-31 | -$16.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$23.60M derived: sum of 2 quarters · filed 2022-02-03 | -$32.20M derived: sum of 3 quarters · filed 2022-02-03 | $0.00 10-K · filed 2022-02-03 |
| 2019-09-30 | -$6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | -$15.30M derived: sum of 2 quarters · filed 2020-10-21 | $16.90M 10-Q · filed 2020-10-21 | $12.30M derived: sum of 4 quarters · filed 2020-10-21 |
| 2019-06-30 | -$8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $23.60M 10-Q · filed 2020-07-22 | $19.00M derived: sum of 3 quarters · filed 2020-07-22 | $11.40M derived: sum of 4 quarters · filed 2020-07-22 |
| 2019-03-31 | $32.20M 10-Q · filed 2020-04-23 | $27.60M derived: sum of 2 quarters · filed 2020-04-23 | $20.00M derived: sum of 3 quarters · filed 2020-04-23 | $13.10M derived: sum of 4 quarters · filed 2020-04-23 |
| 2018-12-31 | -$4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$12.20M derived: sum of 2 quarters · filed 2019-10-22 | -$19.10M derived: sum of 3 quarters · filed 2019-10-22 | $2.10M 10-K · filed 2019-02-06 |
| 2018-09-30 | -$7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$14.50M derived: sum of 2 quarters · filed 2019-10-22 | $6.70M 10-Q · filed 2019-10-22 | $1.30M derived: sum of 4 quarters · filed 2019-10-22 |
| 2018-06-30 | -$6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $14.30M 10-Q · filed 2019-07-24 | $8.90M derived: sum of 3 quarters · filed 2019-07-24 | $1.80M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | $21.20M 10-Q · filed 2019-04-24 | $15.80M derived: sum of 2 quarters · filed 2019-04-24 | $8.70M derived: sum of 3 quarters · filed 2019-04-24 | $1.00M derived: sum of 4 quarters · filed 2019-04-24 |
| 2017-12-31 | -$5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$12.50M derived: sum of 2 quarters · filed 2019-02-06 | -$20.20M derived: sum of 3 quarters · filed 2019-02-06 | $5.30M 10-K · filed 2019-02-06 |
| 2017-09-30 | -$7.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$14.80M derived: sum of 2 quarters · filed 2018-10-23 | $10.70M 10-Q · filed 2018-10-23 | $6.80M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-06-30 | -$7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | $17.80M 10-Q · filed 2018-07-24 | $13.90M derived: sum of 3 quarters · filed 2019-02-06 | $4.40M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-03-31 | $25.50M 10-Q · filed 2018-04-24 | $21.60M derived: sum of 2 quarters · filed 2019-02-06 | $12.10M derived: sum of 3 quarters · filed 2019-02-06 | $4.40M derived: sum of 4 quarters · filed 2019-02-06 |
| 2016-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$13.40M derived: sum of 2 quarters · filed 2019-02-06 | -$21.10M derived: sum of 3 quarters · filed 2019-02-06 | $8.50M 10-K · filed 2019-02-06 |
| 2016-09-30 | -$9.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$17.20M derived: sum of 2 quarters · filed 2017-10-24 | $12.40M 10-Q · filed 2017-10-24 | |
| 2016-06-30 | -$7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $21.90M 10-Q · filed 2017-07-25 | ||
| 2016-03-31 | $29.60M 10-Q · filed 2017-04-25 | |||
| 2015-12-31 | $70.90M 10-K · filed 2018-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |